Tzvia Bader
Co-founder & CEO
Claimed by owner Leal Health
Former names: TrialJectory
AI-based Decision Support Platform for Cancer Treatment
Leal Health
www.prnewswire.com
•
Dec 7, 2022
New Trialjectory Data Shows Triple-Negative Breast Cancer Patients More Likely to Seek Clinical Trial Options Prior to Treatment for Advanced Disease
www.prnewswire.com
•
Dec 5, 2022
Trialjectory Grows Pharmaceutical and Biotech Clinical Trial Partnerships by 800 Percent
www.prnewswire.com
•
Jun 22, 2022
Trialjectory Boasts Over 54 Percent Growth in New Cancer Patient Users from Diverse Ethnic and Racial Backgrounds in Q1 2022
www.prnewswire.com
•
Jun 6, 2022
Trialjectory Presents Poster Highlighting Platform's Effective Cancer Patient Clinical Trial Recruitment at 2022 ASCO Annual Meeting
www.mobihealthnews.com
•
Feb 7, 2022
Trialjectory scores $20M to match cancer patients to clinical trials
techcrunch.com
•
Nov 12, 2021
Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups
pharmaphorum.com
•
Sep 27, 2021
YonaLink, TrialJectory get $1m grant for patient recruitment tool -
www.precisiononcologynews.com
•
Sep 10, 2021
Clinical Trial Matching Startup's Survey Spotlights NGS Access Barriers, Patient Awareness
www.forbes.com
•
Aug 17, 2021
Startup Helps Cancer Patients Find Clinical Trials, Offering New Hope And More Options
www.cancernetwork.com
•
Mar 26, 2021
Tzvia Bader Discusses the TrialJectory Platform Connecting Patients With Cancer to Clinical Trials
www.prnewswire.com
•
Mar 9, 2021
TrialJectory Achieves 500 Percent Year-Over-Year Growth as Cancer Patients and Pharmaceutical Industry Increasingly Leverage Proprietary AI Platform in COVID-19 Pandemic
www.wfmz.com
•
Nov 20, 2020
TIME Selects TrialJectory's AI-Powered, Clinical Trial-Matching Platform for '100 Best Inventions of 2020' List
www.prnewswire.com
•
Jan 28, 2020
TrialJectory and Precipio Partner to Provide Cancer Patients with First-of-its-Kind Diagnostic and Clinical Trial-Matching Service
techcrunch.com
•
Dec 17, 2019
Trialjectory uses self-reported clinical data to match cancer patients with clinical trials
www.calcalistech.com
•
Nov 4, 2018
This Startup Helps Patients Find their Best Shot at Surviving Cancer
About
Leal Health is a growing patient-first, AI-powered decision support platform dedicated to expediting access to all available advanced cancer treatments.
Working directly with patients, healthcare providers, and pharmaceutical companies, Leal Health provides patients with instant access to precise, advanced cancer treatment while also enabling the pharmaceutical and biotech industries to develop patient-centric clinical trials and provide real-time analytics and understanding of patient barriers and motivations.
Leal Health was chosen as one of TIME magazine’s “100 Best Inventions of 2020,” was named an honoree in Fast Company’s 2021 “World-Changing Ideas Awards” in the AI and data category, and recognized as the “Leader in Patient Recruitment and Enrollment” by CBInsights.
Working directly with patients, healthcare providers, and pharmaceutical companies, Leal Health provides patients with instant access to precise, advanced cancer treatment while also enabling the pharmaceutical and biotech industries to develop patient-centric clinical trials and provide real-time analytics and understanding of patient barriers and motivations.
Leal Health was chosen as one of TIME magazine’s “100 Best Inventions of 2020,” was named an honoree in Fast Company’s 2021 “World-Changing Ideas Awards” in the AI and data category, and recognized as the “Leader in Patient Recruitment and Enrollment” by CBInsights.
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
United States
News
(15)
www.prnewswire.com
•
Dec 7, 2022
New Trialjectory Data Shows Triple-Negative Breast Cancer Patients More Likely to Seek Clinical Trial Options Prior to Treatment for Advanced Disease
www.prnewswire.com
•
Dec 5, 2022
Trialjectory Grows Pharmaceutical and Biotech Clinical Trial Partnerships by 800 Percent
www.prnewswire.com
•
Jun 22, 2022
Trialjectory Boasts Over 54 Percent Growth in New Cancer Patient Users from Diverse Ethnic and Racial Backgrounds in Q1 2022
www.prnewswire.com
•
Jun 6, 2022
Trialjectory Presents Poster Highlighting Platform's Effective Cancer Patient Clinical Trial Recruitment at 2022 ASCO Annual Meeting
www.mobihealthnews.com
•
Feb 7, 2022
Trialjectory scores $20M to match cancer patients to clinical trials
techcrunch.com
•
Nov 12, 2021
Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups
pharmaphorum.com
•
Sep 27, 2021
YonaLink, TrialJectory get $1m grant for patient recruitment tool -
www.precisiononcologynews.com
•
Sep 10, 2021
Clinical Trial Matching Startup's Survey Spotlights NGS Access Barriers, Patient Awareness
www.forbes.com
•
Aug 17, 2021
Startup Helps Cancer Patients Find Clinical Trials, Offering New Hope And More Options
www.cancernetwork.com
•
Mar 26, 2021
Tzvia Bader Discusses the TrialJectory Platform Connecting Patients With Cancer to Clinical Trials
www.prnewswire.com
•
Mar 9, 2021
TrialJectory Achieves 500 Percent Year-Over-Year Growth as Cancer Patients and Pharmaceutical Industry Increasingly Leverage Proprietary AI Platform in COVID-19 Pandemic
www.wfmz.com
•
Nov 20, 2020
TIME Selects TrialJectory's AI-Powered, Clinical Trial-Matching Platform for '100 Best Inventions of 2020' List
www.prnewswire.com
•
Jan 28, 2020
TrialJectory and Precipio Partner to Provide Cancer Patients with First-of-its-Kind Diagnostic and Clinical Trial-Matching Service
techcrunch.com
•
Dec 17, 2019
Trialjectory uses self-reported clinical data to match cancer patients with clinical trials
www.calcalistech.com
•
Nov 4, 2018
This Startup Helps Patients Find their Best Shot at Surviving Cancer
The Team
(6)
GG
Guy Gildor
Co-founder & CTO
AG
Avital Gaziel
Co-founder & Head of Medical Affairs
NB
Noam Barnea
Co-founder & VP Product
NB
Noam Barnea
VP R&D
RT
Rita Tochner
Head of Operations
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Undisclosed Round
$500K
1 Investors
$500K
Seed
$2.7M
Dec 2019
1 Investors
$2.7M
A Round
$5M
Feb 2021
4 Investors
$5M
A Round
$20M
Feb 2022
5 Investors
$20M
Non-Equity Funding
Grant
Undisclosed
Sep 2021
1 Grantors
Undisclosed
Media gallery
(5)
For the Trialjectory Team, its Personal.
How clinical trial revolutionize cancer care
How to fight cancer and win? clinical trial changing the world of cancer care
Trialjectory.com Demo
Trialjectory - our story
Locations
Israel
King George Street 48, Tel Aviv-Yafo, Israel
Offices Abroad
700 Canal St, Stamford, CT, USA
Locations
Israel
King George Street 48, Tel Aviv-Yafo, Israel
Offices Abroad
700 Canal St, Stamford, CT, USA
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,